Amedisys Inc. (AMED), a leading provider of home health and hospice care services, is a company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on AMED’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Amedisys could be a solid choice for investors.
Current Quarter Estimates for AMED
In the past 30 days, 2 estimates have gone higher for Amedisys with no downward revision in the same time period. The trend has been pretty favorable too, with estimates increasing from 1 penny per share 30 days ago, to 17 cents a share today, a move of 1600.0%.
Current Year Estimates for AMED
Meanwhile, Amedisys’s current year figures have seen 2 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, increasing from 6 cents per share 30 days ago to 16 cents per share today, an increase of 266.7%.
Bottom Line
The stock has also started to move higher lately, adding 11.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment